202406-79-9
Chemical Structure
Cytidine-13C9,15N3
Synonym(s): Cytosine β-D-riboside-13C9,15N3;Cytosine-1-β-D-ribofuranoside-13C9,15N3
- CAS No.: 202406-79-9
- Formula:13C9H1315N3O5
- Molecular Weight:255.13
IUPAC Name: 4-(amino-15N)-1-((2R,5R)-3,4-dihydroxy-5-(hydroxymethyl-13C)tetrahydrofuran-2-yl-2,3,4,5-13C4)pyrimidin-2(1H)-one-2,4,5,6-13C4-1,3-15N2
InChIKey: UHDGCWIWMRVCDJ-XQLVKTAWSA-N
SMILES: O[13CH]1[13CH](O)[13C@H]([15N]2[13C]([15N]=[13C]([15NH2])[13CH]=[13CH]2)=O)O[13C@@H]1[13CH2]O
Biological Activity: Cytidine-13C9,15N3 is the 13C and 15N labeled Cytidine[1]. Cytidine is a pyrimidine nucleoside and acts as a component of RNA. Cytidine is a precursor of uridine. Cytidine controls neuronal-glial glutamate cycling, affecting cerebral phospholipid metabolism, catecholamine synthesis, and mitochondrial function[2][3][4].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Cytidine-13C9,15N3 | 98.9% | Cytidine-13C9,15N3 is the 13C and 15N labeled Cytidine. Cytidine is a pyrimidine nucleoside and acts as a component of RNA. Cytidine is a precursor of uridine. Cytidine controls neuronal-glial glutamate cycling, affecting cerebral phospholipid metabolism, catecholamine synthesis, and mitochondrial function. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Cytidine (Standard) | 99.97% | Cytidine (Standard) is the analytical standard of Cytidine. This product is intended for research and analytical applications. Cytidine is a pyrimidine nucleoside and acts as a component of RNA. Cytidine is a precursor of uridine. Cytidine controls neuronal-glial glutamate cycling, affecting cerebral phospholipid metabolism, catecholamine synthesis, and mitochondrial function. In Vivo:Cytidine decreases glutamate/glutamine levels and induces earlier improvement of depressive symptoms. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Cytidine-d13 | Cytidine-d13 (Cytosine β-D-riboside-d13) is deuterium labeled Cytidine (HY-B0158). Cytidine is a pyrimidine nucleoside and acts as a component of RNA. Cytidine is a precursor of uridine. Cytidine controls neuronal-glial glutamate cycling, affecting cerebral phospholipid metabolism, catecholamine synthesis, and mitochondrial function. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Cytidine-1',2',3',4',5'-13C5 | Cytidine-1',2',3',4',5'-13C5 is the 13C-labeled Cytidine (HY-B0158). Cytidine is a pyrimidine nucleoside and acts as a component of RNA. Cytidine is a precursor of uridine. Cytidine controls neuronal-glial glutamate cycling, affecting cerebral phospholipid metabolism, catecholamine synthesis, and mitochondrial function. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Cytidine-13C | 99.0% | Cytidine-13C is the 13C labeled Cytidine. Cytidine is a pyrimidine nucleoside and acts as a component of RNA. Cytidine is a precursor of uridine. Cytidine controls neuronal-glial glutamate cycling, affecting cerebral phospholipid metabolism, catecholamine | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Cytidine-13C9 | 98.69% | Cytidine-13C9 (Cytosine β-D-riboside-13C9) is 13C labeled Cytidine (HY-B0158). Cytidine is a pyrimidine nucleoside and acts as a component of RNA. Cytidine is a precursor of uridine. Cytidine controls neuronal-glial glutamate cycling, affecting cerebral phospholipid metabolism, catecholamine synthesis, and mitochondrial function. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Cytidine-13C-1 | Cytidine-13C-1 is the 13C labeled Cytidine. Cytidine is a pyrimidine nucleoside and acts as a component of RNA. Cytidine is a precursor of uridine. Cytidine controls neuronal-glial glutamate cycling, affecting cerebral phospholipid metabolism, catecholami | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Cytidine-15N3 | 99.3% | Cytidine-15N3 is the 15N labeled Cytidine. Cytidine is a pyrimidine nucleoside and acts as a component of RNA. Cytidine is a precursor of uridine. Cytidine controls neuronal-glial glutamate cycling, affecting cerebral phospholipid metabolism, catecholamine synthesis, and mitochondrial function. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Cytidine-d2-1 | Cytidine-d2-1 is the deuterium labeled Cytidine. Cytidine is a pyrimidine nucleoside and acts as a component of RNA. Cytidine is a precursor of uridine. Cytidine controls neuronal-glial glutamate cycling, affecting cerebral phospholipid metabolism, catech | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Cytidine-d2 | Cytidine-d2 is the deuterium labeled Cytidine. Cytidine is a pyrimidine nucleoside and acts as a component of RNA. Cytidine is a precursor of uridine. Cytidine controls neuronal-glial glutamate cycling, affecting cerebral phospholipid metabolism, catecholamine synthesis, and mitochondrial function. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Cytidine-d | Cytidine-d is the deuterium labeled Cytidine. Cytidine is a pyrimidine nucleoside and acts as a component of RNA. Cytidine is a precursor of uridine. Cytidine controls neuronal-glial glutamate cycling, affecting cerebral phospholipid metabolism, catechol | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Cytidine | 99.97% | Cytidine is a pyrimidine nucleoside and acts as a component of RNA. Cytidine is a precursor of uridine. Cytidine controls neuronal-glial glutamate cycling, affecting cerebral phospholipid metabolism, catecholamine synthesis, and mitochondrial function. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
- [1]. Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019 Feb;53(2):211-216. [Content Brief]
- [2]. Jonas DA, et al. Safety considerations of DNA in food. Ann Nutr Metab. 2001;45(6):235-54. [Content Brief]
- [3]. Machado-Vieira R, et, al. New therapeutic targets for mood disorders. ScientificWorldJournal. 2010 Apr 1310:713-26. [Content Brief]